Journal of population therapeutics and clinical pharmacology = Journal de la thérapeutique des populations et de la pharamcologie clinique
-
J Popul Ther Clin Pharmacol · Jan 2011
Adverse events related to medications identified by a Canadian poison centre.
Poison centres are an underutilized source of information on adverse events related to medications, including therapeutic errors and adverse drug reactions. ⋯ Calls to poison centres provide a potentially valuable source of information on adverse events related to medications that are likely not reported elsewhere. Establishment of a mechanism to routinely share information from all Canadian poison centres with relevant national drug safety programs (e.g., MedEffect™ Canada) will provide a supplementary source of information and contribute to building capacity for detection of sentinel events and pharmacosurveillance.
-
The cornerstone of Canadian response to the pandemic H1N1 outbreak was the Canadian Pandemic Influenza Plan. The Plan was based on a moderate scenario, articulated around 7 pillars: surveillance, antiviral drugs, vaccines, public health measures, clinical care, communications, and research. This presentation provides an overview of Canada's response to pandemic H1N1. It presents the context (Who did what? How? …), what happened (focusing on pregnant women), addresses making decisions together, and includes some post-H1N1 reflections.
-
The risk of depression in women is greatest during the child-bearing years. Considering that about 50% of pregnancies are unplanned, women may become pregnant while on antidepressants, may have their depression or anxiety relapse during pregnancy or postpartum, or may be unwell and untreated before and during pregnancy and the postpartum period. The impact of the symptoms of depression and anxiety can cause risk to the mother and also have a negative effect on child development. This presentation is intended to assist in understanding the impact of untreated maternal depression and anxiety on fetus, neonate, child and mother; to review the effects of fetal exposure to psychotropic medications (antidepressants); and to summarize general management of perinatal mood/anxiety disorders.